Passive Conjugation Kit
| Catalog number: | B2015391 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 1 kit |
| Molecular Weight or Concentration: | N/A |
| Supplied as: | Kit |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | 2-8 C |
| Keywords: | Passive Conjugation Kit |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Lin S, Han SQ, Liu YB, Xu WG, Guan GY. Chemiluminescence immunoassay for chloramphenicol Anal Bioanal Chem. 2005 Jul;382(5):1250-5.
- Zotz JS, Wlbing F, Lassnig C, Kauffmann M, Schulte U, Kolb A, Whitelaw B, Mller M, Biedermann T, Huber M. CD13/aminopeptidase N is a negative regulator of mast cell activation FASEB J. 2016 Jun;30(6):2225-35.
- Hu R, Zheng H, Cao J, Davoudi Z, Wang Q. Synthesis and In Vitro Characterization of Carboxymethyl Chitosan-CBA-Doxorubicin Conjugate Nanoparticles as pH-Sensitive Drug Delivery Systems J Biomed Nanotechnol. 2017 Dec 1;13(9):1097-1105.
- Johnson CM, Grossman AD. Integrative and Conjugative Elements (ICEs): What They Do and How They Work Annu Rev Genet. 2015;49:577-601.
- Arslan FB, Ozturk Atar K, Calis S. Antibody-mediated drug delivery Int J Pharm. 2021 Mar 1;596:120268.
- Dockery L, Daniel MC. Dendronized Systems for the Delivery of Chemotherapeutics Adv Cancer Res. 2018;139:85-120.
- Souza C, Pellosi DS, Tedesco AC. Prodrugs for targeted cancer therapy Expert Rev Anticancer Ther. 2019 Jun;19(6):483-502.
- Mahmoudi T, Pourhassan-Moghaddam M, Shirdel B, Baradaran B, Morales-Narvez E, Golmohammadi H. (Nano)tag-antibody conjugates in rapid tests J Mater Chem B. 2021 Jul 14;9(27):5414-5438.
- Bennie LA, McCarthy HO, Coulter JA. Enhanced nanoparticle delivery exploiting tumour-responsive formulations Cancer Nanotechnol. 2018;9(1):10.
